Yoo Dae Young, Choi Jung Hoon, Kim Woosuk, Nam Sung Min, Jung Hyo Young, Kim Jong Hwi, Won Moo-Ho, Yoon Yeo Sung, Hwang In Koo
Seoul National University, Seoul, South Korea.
Neurol Res. 2013 Oct;35(8):813-20. doi: 10.1179/1743132813Y.0000000217. Epub 2013 May 3.
Luteolin, a common flavonoid from many plants, has various pharmacological activities, including a memory-improving effect. In this study, we investigated the effects of luteolin on spatial memory, cell proliferation, and neuroblast differentiation in the hippocampal dentate gyrus in a rat model of scopolamine (SCO)-induced amnesia.
Scopolamine was subcutaneously administered for 28 days via an Alzet minipump (44 mg/ml delivered at 2·5 μl/h) along with a daily intraperitoneal administration of vehicle (saline) 10 mg/kg luteolin or 5 mg/kg galantamine (GAL) (a control drug for acetylcholinesterase (AChE) inhibitor) for 28 days.
The administration of SCO significantly decreased the spatial alteration percentage in the Y-maze test compared to that in the vehicle (saline)-treated group. The administration of luteolin or GAL significantly improved the spatial alteration percentage compared to that in the SCO-treated group. Similarly, the administration of SCO significantly decreased the cell proliferation (Ki67-positive cells) and neuroblast differentiation (doubleocortin-positive cells) in the dentate gyrus. The administration of luteolin or GAL significantly mitigated the SCO-induced reduction of Ki67- and doublecortin-immunoreactive cells in the dentate gyrus. In addition, the administration of luteolin significantly decreased the lipid peroxidation (malondialdehyde (MDA) levels) and increased the brain-derived neurotrophic factor (BDNF) and AChE levels in the hippocampal homogenates compared to the SCO-treated group.
These results suggest that the luteolin treatment improves the SCO-induced reduction of cell proliferation and neuroblast differentiation in the dentate gyrus. The mechanism underlying the amelioration of SCO-induced amnesia by luteolin may be associated with the increase in BDNF, acetylcholine, and the decrease in lipid peroxidation.
木犀草素是一种常见于多种植物中的黄酮类化合物,具有多种药理活性,包括改善记忆的作用。在本研究中,我们在东莨菪碱(SCO)诱导的失忆大鼠模型中,研究了木犀草素对海马齿状回空间记忆、细胞增殖和神经母细胞分化的影响。
通过Alzet微型泵皮下注射东莨菪碱28天(以2.5 μl/h的速度输送44 mg/ml),同时每天腹腔注射溶媒(生理盐水)、10 mg/kg木犀草素或5 mg/kg加兰他敏(GAL,一种乙酰胆碱酯酶(AChE)抑制剂的对照药物),持续28天。
与溶媒(生理盐水)处理组相比,SCO给药显著降低了Y迷宫试验中的空间改变百分比。与SCO处理组相比,木犀草素或GAL给药显著提高了空间改变百分比。同样,SCO给药显著降低了齿状回中的细胞增殖(Ki67阳性细胞)和神经母细胞分化(双皮质素阳性细胞)。木犀草素或GAL给药显著减轻了SCO诱导的齿状回中Ki67和双皮质素免疫反应性细胞的减少。此外,与SCO处理组相比,木犀草素给药显著降低了海马匀浆中的脂质过氧化(丙二醛(MDA)水平),并提高了脑源性神经营养因子(BDNF)和AChE水平。
这些结果表明,木犀草素治疗可改善SCO诱导的齿状回细胞增殖和神经母细胞分化的减少。木犀草素改善SCO诱导失忆的潜在机制可能与BDNF、乙酰胆碱的增加以及脂质过氧化的减少有关。